Ketamine: A Potential Leap Forward In Opioid Addiction Medication

rredick August 15, 2023

Photo credit: Cole Burston/ AFP via Getty Images

Buprenorphine is a crucial medicine for many patients in treatment for opioid use disorder (OUD). But with the rise of deadly fentanyl, buprenorphine is becoming much harder to use effectively. That’s where another medicine, ketamine, is showing immense promise.

The entrance of fentanyl into the U.S. illicit drug supply has had many tragic results. Topping that list is an explosion of opioid-related deaths, now at over 80,000 a year. But another serious consequence is the increasing difficulty of applying some of the most effective medicines for the disorder.

Buprenorphine, widely used to help patients overcome craving and physical dependency on opioids, is far less potent that fentanyl. Consequently, many of those attempting to use buprenorphine have suffered exceptionally painful and traumatic symptoms known as “precipitated withdrawal.” The step down from fentanyl to buprenorphine, it appears, is often simply too great—so great that many OUDS suffers quit using buprenorphine altogether.

Enter ketamine, an anesthetic with moderate hallucinogenic properties. Recently, doctors in several West Coast locations have discovered that very small doses of ketamine administered alongside buprenorphine have greatly decreased, or even eliminated, those excruciating symptoms of withdrawal. The results are preliminary but striking. Ketamine also has the advantage of being relatively well-studied and widely-used surgical drug. If the good results continue to accumulate, access to ketamine should be far easier and more widespread than for experimental medications.

You can read the full report here:

To ease start of addiction treatment, doctors find surprise aid: ketamine

rredick

Fourth Largest Health Insurer U.S. Is Sued For Fraudulent, AI-Calculated Denial of Claims

If you’ve been thinking that concerns about artificial intelligence are overblown, this story may change your mind. But as with many abuses of new technology, human greed also plays a role.

rredick March 12, 2024

The Biden Administration Is Easing Access to Methadone

Fentanyl and other opioids are cutting lives short in numbers we’ve never seen before. Unfortunately, this health emergency hasn’t yet generated the national response we need. But there are some encouraging steps in the right direction—and among them are these new rules on access to methadone.

rredick March 5, 2024

What Happens In Recovery: A Young Man’s Journey in 2 ¼ Minutes

rredick February 27, 2024

Fentanyl Is Making “The Worst Overdose Crisis in American History” Worse All The Time

Many factors have combined to make recent years the deadliest in history for U.S. drug overdose deaths. At the same time, many policy responses, from bold to incremental, are on the negotiating table. Unfortunately, as this report from Politico explains, most of them are likely to stay there awhile. For now, in the absence of national leadership, it’s up to others to carry on.

rredick November 21, 2023

Positive Childhood Experiences Are Linked to Emotional Health and Resilience—Even in Households Experiencing Trauma

For decades, pediatric research has focused on negative childhood experiences (NCEs) and their effects on children’s wellbeing. Until recently, however, positive childhood experiences (PCEs) went mostly unstudied. Now that’s beginning to change, and the findings are encouraging to say the least.

rredick September 20, 2023

Ozempic, Widely Used for Diabetes and Weight Loss, Has Potential Substance Use Disorder Benefits As Well

It was developed to help regulate blood sugar in diabetics and pre-diabetics. It’s widely (though unofficially) used for weight loss. Now semaglutide (brand name Ozempic) is showing promise for SUD sufferers as well.

rredick September 12, 2023

Fentanyl Deaths In Communities of Color: A Crisis “Decades In the Making”

A new report from the Centers for Disease Control and Prevention reveals the unequal effects of the opioid crisis on Black, Native American, Hispanic, and white populations in the United States. Fentanyl deaths in particular have skyrocketed for all groups—but far more so in Black communities. Understanding the lasting effects of discrimination is essential, both for grasping the problem and seeking solutions.

rredick September 5, 2023

Borderline Personality Disorder: A Family Takes Its Caring to the Next Level

Borderline Personality Disorder (BPD) affects nearly 6% of Americans at some point in their lives, but research, treatment, and support for the condition lags far behind other serious mental illnesses. Paula Tusiani-Eng and her parents know first-hand what it’s like to live with, and eventually lose, a loved one suffering from BPD. Their story is remarkable not just because of those challenges, but because of what they decided to do next.

rredick August 22, 2023

White Patients Receive Opioid Addiction Medication at More Than Twice the Rate of Black Patients

In a new report, the New England Journal of Medicine reveals that Black and Native American patients struggling with opioid use were less than half as likely to be prescribed a crucial treatment medicine as White patients. The reasons are numerous, but many stem from what the reports’ authors call “the racial segregation of healthcare” in the United States.

rredick August 2, 2023

Bromazolam, Delivered By Mail, Is Killing Canadians in Startling Numbers

Over 20,000 Canadians have died of opioid-related causes since 2020. Many of these deaths involved opioids mixed with Bromazolam or similar illicit sedatives—and most, it appears, reach users via Canadian mail. Until that pipeline can be shut down, awareness may be the best protection families can hope for.

rredick July 25, 2023

Photo credit: Cole Burston/ AFP via Getty Images

processing...

Related Posts from "What's News"